Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heartport Stock Up 97% In September On Acquisition Interest, New Products

This article was originally published in The Gray Sheet

Executive Summary

Continued strong interest in minimally invasive surgery by cardiac surgeons, acquisition of competitors in the sector, a new CEO and several recent product introductions appeared to help stimulate a 97.3% gain in Heartport stock in September. The issue gained 2-1/4 points to close the month at 4-9/16.

You may also be interested in...



ArthroCare's Entry Into Spine Surgery Market Attracts Backers To Stock

ArthroCare anticipates pursuing additional spinal applications within the next year for its Coblation-based surgical tools following the firm's recent entry into the European spine surgery market.

Candela Stock Doubles In April As Aesthetic Lasers, Profits Attract Investors

Continued strong demand for Candela's flagship aesthetic lasers, including the GentleLase for hair removal and ScleroPlus for vascular lesions, coupled with the release of strong third-quarter financial results ahead of some analysts' expectations, drove the firm's stock price in April. The issue gained 9-3/4 points to close at 18-3/4 for the month, an increase of 108.3%.

ADAC Labs

Law firm of Barrack, Rodos & Bacine adds to a growing list of class action suits maintaining that the company's officers issued "false and misleading" financial results from Jan. 1996 through Dec. 1998. The suit, filed in San Francisco federal court, was sparked by ADAC's Dec. 29 announcement that financial results for 1996-98 would be restated and that the adjustments would "have a material adverse impact" on fiscal 1996 and 1997 results

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel